In an interview with Brittany Craiglow, MD, FAAD, dermatologist at Dermatology Physicians of Connecticut in Fairfield, she advocates for combination therapies using baricitinib to treat pediatric ...

The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and ...

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...

2 "Early onset alopecia areata can be more severe ... Phase 3 trial involving children ages 6 to under 18 years with severe AA, as measured by a Severity of Alopecia Tool (SALT) score of ≥ ...

The doll is a popular toy for children, but it also has name recognition among adults and is a fashion icon. Dressing Licca-chan with a headscarf that alopecia areata patients use would also send ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...